Current state and precision management of neonatal continuous renal replacement therapy

  • GONG Xiaohui ,
  • YAN Chongbing ,
  • CAI Cheng ,
  • QIU Gang
Expand
  • Shanghai Jiaotong University, Shanghai Children’s Hospital, Shanghai  200062, China

Received date: 2018-07-15

  Online published: 2018-07-15

Abstract

 Neonatal acute kidney injury (AKI) is more likely developed in preterm and very low birth weight infants. The incidence of AKI is increasing year by year in the neonatal intensive care unit. Due to the lack of effective prevention and control measures, the mortality rate is extremely high and the prognosis is very poor. Continuous renal replacement therapy (CRRT) is currently the ideal method for the treatment of neonatal AKI. At present, CRRT technology has been used in newborns both at home and abroad for more than 30 years. Although considerable treatment experience has been accumulated, a large number of problems remain to be solved. This article reviews the present state and precision management of CRRT in neonates.

Cite this article

GONG Xiaohui , YAN Chongbing , CAI Cheng , QIU Gang . Current state and precision management of neonatal continuous renal replacement therapy[J]. Journal of Clinical Pediatrics, 2018 , 36(7) : 553 . DOI: 10.3969/j.issn.1000-3606.2018.07.019

Outlines

/